Medication info
Dapaenzenta Tablet 10/5 mg (Dapagliflozin, Linagliptin)

Dapaenzenta Tablet 10/5 mg (Dapagliflozin, Linagliptin)

Prescription medicationTablet
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tabletLinagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
28 tablets/box [(7 tablets/PTP × 4)], 30 tablets/bottle
Approval status
Active

MFDS item code 202400937 · Approved 2024.04.22

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who uses it
Adults
Adult dosage
This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving dapagliflozin 10 mg and linagliptin 5 mg. It is recommended that renal function be assessed before treatment with this medicine and periodically thereafter. - If the estimated glomerular filtration rate (eGFR) is 45mL/min/1.73m2 or higher No dose adjustment based on renal function is necessary. - Use of this medicine is not recommended if the eGFR is less than 45 mL/min/1.73m2. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication helps control blood sugar in patients with type 2 diabetes by using dapagliflozin and linagliptin together. It aids in effectively managing blood sugar levels along with dietary and exercise therapies. This contributes to improved blood sugar control and diabetes treatment.

Dosage and Administration

Adult dosage

This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving dapagliflozin 10 mg and linagliptin 5 mg. It is recommended that renal function be assessed before treatment with this medicine and periodically thereafter. - If the estimated glomerular filtration rate (eGFR) is 45mL/min/1.73m2 or higher No dose adjustment based on renal function is necessary. - Use of this medicine is not recommended if the eGFR is less than 45 mL/min/1.73m2. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.

Precautions

It is very important to avoid this medication in certain patients. For instance, it should not be administered to patients who have had allergic reactions to the main ingredients or excipients, type 1 diabetes patients, patients on dialysis, and patients with a history of myocardial infarction. This medication should be used cautiously in patients with reduced fluid volume or impaired kidney function. Since it can lower blood pressure or affect kidney function, the patient's fluid status and kidney function should be thoroughly evaluated before administration, and symptoms of hypotension or signs of kidney abnormalities should be closely monitored after administration. Moreover, patients taking medications that can induce hypoglycemia, such as insulin or sulfonylureas, may have an increased risk of hypoglycemia, so insulin dosage adjustments may be necessary when using this medication concurrently. Experience with this drug in heart failure patients, especially those with severe heart failure, is limited, so caution is advised. Skin abnormalities like acute pancreatitis or blistering diseases may occur, so if persistent abdominal pain or skin abnormalities arise during use, consult a doctor immediately. This medication may increase the risk of genital infections and urinary tract infections, so prompt treatment is necessary if symptoms of infection appear. Elderly patients are at higher risk for kidney function impairment and decreased fluid volume, thus requiring greater caution during administration. It is recommended that pregnant or breastfeeding women do not use this medication. Finally, during treatment with this medication, symptoms such as weight loss, hypoglycemia, dizziness, palpitations, and increased urination may occur, thus any such symptoms should be discussed with a doctor.

Side effects

  • Hypersensitivity
  • symptomatic hypotension
  • acute kidney injury
  • hypotension
  • increased creatinine
  • phosphorus
  • elevated parathyroid hormone
  • hypoglycemia
  • acute pancreatitis
  • pseudo-pemphigus
Show 210 more
  • constipation
  • diarrhea
  • dizziness
  • palpitations
  • vulvar pruritus
  • hyperhidrosis
  • cystitis
  • urinary tract infection
  • weight loss
  • vulvitis
  • balanitis
  • genital infection
  • fungal infection
  • perineal necrosis
  • thirst
  • diabetic ketoacidosis
  • vertigo
  • dry mouth
  • low back pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • elevated hematocrit
  • increased blood creatinine
  • elevated blood urea
  • rash
  • decreased appetite
  • dehydration
  • sensory abnormalities
  • cerebral infarction
  • nerve compression
  • weakness
  • pain
  • keratitis
  • hemoptysis
  • cerebral hemorrhage
  • peripheral arterial occlusion
  • angina pectoris
  • myocardial infarction
  • biliary calculi
  • cholangitis
  • alcoholic cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • sensory loss
  • increased blood lactate
  • lymphocytopenia
  • hypertriglyceridemia
  • cough
  • oral ulcers
  • rash
  • severe and disabling arthralgia
  • rhabdomyolysis
  • increased amylase
  • nasopharyngitis
  • hypersensitivity
  • angioedema
  • urticaria
  • constipation
  • pseudo-pemphigus
  • headache
  • drowsiness
  • insomnia
  • tinnitus
  • pruritus
  • anxiety
  • erectile dysfunction
  • goiter
  • anemia
  • dyspepsia
  • vomiting
  • urinary retention
  • hyperkalemia
  • hypochromic anemia
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased ALT
  • increased AST
  • hair loss
  • dermatitis
  • dry skin
  • allergic dermatitis
  • contact dermatitis
  • diabetic foot ulcer
  • excessive sweating eczema
  • nummular eczema
  • eczema
  • hyperkeratosis
  • nail pigmentation
  • skin lesions
  • urticaria
  • diaphoresis
  • skin lesions
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • myopathy
  • myalgia
  • osteoarthritis
  • ligament sprain
  • dry eye
  • cataract
  • diabetic retinopathy
  • dyspnea
  • orthostatic hypotension
  • vertigo
  • benign prostatic hyperplasia
  • fever
  • facial swelling
  • death
  • fatigue
  • chest pain
  • chest discomfort
  • peripheral edema
  • generalized edema
  • hunger
  • vaginal discharge
  • menstrual irregularities
  • vaginal discharge
  • anxiety disorder
  • nocturia
  • insomnia
  • depression
  • anxiety
  • epistaxis
  • pharyngodynia
  • allergic rhinitis
  • asthma
  • rhinorrhea
  • pulmonary mass
  • osteoporosis
  • arthropathy
  • musculoskeletal discomfort
  • myositis
  • soft tissue mass
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • contusion
  • bone contusion
  • concussion
  • laceration
  • congestive heart failure
  • unstable angina
  • cardiac arrest
  • eye discomfort
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid edema
  • ocular hypertension
  • visual impairment
  • vitreous floaters
  • hearing loss
  • male pattern baldness
  • diabetic foot complications
  • hyperhidrosis
  • hair loss
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • benign duodenal neoplasm
  • benign skin neoplasm
  • gastric cancer
  • colorectal cancer
  • pancreatic cancer
  • anxiety
  • mood disorder
  • nocturia
  • increased appetite
  • decreased appetite
  • hyperglycemia
  • inadequate control of diabetes
  • malnutrition
  • hyponatremia
  • dehydration
  • drowsiness
  • speech disturbance
  • postherpetic neuralgia
  • paresis
  • syncope
  • Alzheimer’s dementia
  • palpitations
  • angina pectoris
  • acute myocardial infarction
  • palpitations
  • unstable angina
  • cardiac arrest
  • hematuria
  • proteinuria
  • stress urinary incontinence
  • polyuria
  • hypotension
  • flushing
  • hepatic steatosis
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • cholelithiasis
  • hearing loss
  • vertigo
  • erectile dysfunction
  • goiter
  • kidney transplant failure
  • anemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air or moisture. It is best kept at room temperature between 1 degree and 30 degrees.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

28 tablets/box [(7 tablets/PTP × 4)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.